The challenge for successful CF gene therapy for CF is to express the normal CFTR coding sequences in sufficient numbers of airway epithelial cells on a persistent basis without significant toxicity. In the past, our program has focused on achieving these goals using adenovirus (Ad) vectors. Although we have achieved considerable success, despite intense efforts to develop Ad vectors to circumvent host responses that limit Ad-mediated gene transfer, host defense arrayed against Ad vectors are so robust that strategies to circumvent anti-Ad host responses and improve efficiency of Ad entry and trafficking are insufficient to achieve the goal of gene therapy for CF. In this context, over the past 18 months, we have developed strategies to achieve persistent CFTR expression using adenoassociated virus (AAV) and lentivirus vectors. To be useful, both vector systems have to improve entry efficiency into the airway epithelium, and for AAV, size constraints make it difficult to transfer the full length normal CFTR coding sequences controlled by a robust constitutive promoter or, better yet, the 5' flanking region of the normal CFTR gene. This refocused P01, representing a collaboration of the Weill Cornell CF Gene Therapy program with the Wilson laboratory at U. Pennsylvania, is designed to overcome these challenges. Together with the Crystal laboratory development of """"""""segmental trans-splicing"""""""", which functions at the mRNA level to double the genetic cargo space of any vector system, and the development in the Wilson laboratory of novel AAV serotypes and pseudotyped lentiviruses with high efficiency for gene transfer to the respiratory epithelium, we have combined our efforts and refocused our CF gene therapy program to novel AAV and pseudotyped lentivirus gene transfer vectors to achieve the goals of transfer and persistent expression of normal human CFTR coding sequences in airway epithelium. The proposal includes: Project 1, G. Gao, AAV Vectors Based on New Serotypes; Project 2, P. Leopold, Intracellular Trafficking of Novel AAV Serotypes; Project 3, R. Crystal, AAV-mediated Gene Therapy for CF Using Segmental Trans-splicing; Project 4, J. Wilson, Novel Lentiviral Pseudotypes; Core A, S. Kaminsky, Vector; Core B, N. Wivel, Animal Models; and Core C, R. Crystal, Administrative.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Program Projects (P01)
Project #
Application #
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
Banks-Schlegel, Susan P
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Weill Medical College of Cornell University
Schools of Medicine
New York
United States
Zip Code
Ryan, Dorothy M; Vincent, Thomas L; Salit, Jacqueline et al. (2014) Smoking dysregulates the human airway basal cell transcriptome at COPD risk locus 19q13.2. PLoS One 9:e88051
Dvorak, Anna; Tilley, Ann E; Shaykhiev, Renat et al. (2011) Do airway epithelium air-liquid cultures represent the in vivo airway epithelium transcriptome? Am J Respir Cell Mol Biol 44:465-73
Krause, Anja; Whu, Wen Zhu; Xu, Yaqin et al. (2011) Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF. Vaccine 29:2131-9
Limberis, Maria P; Bell, Christie L; Heath, Jack et al. (2010) Activation of transgene-specific T cells following lentivirus-mediated gene delivery to mouse lung. Mol Ther 18:143-50
Song, Yuhu; Lou, Howard H; Boyer, Julie L et al. (2009) Functional cystic fibrosis transmembrane conductance regulator expression in cystic fibrosis airway epithelial cells by AAV6.2-mediated segmental trans-splicing. Hum Gene Ther 20:267-81
Vandenberghe, L H; Breous, E; Nam, H-J et al. (2009) Naturally occurring singleton residues in AAV capsid impact vector performance and illustrate structural constraints. Gene Ther 16:1416-28
Fein, David E; Limberis, Maria P; Maloney, Sean F et al. (2009) Cationic lipid formulations alter the in vivo tropism of AAV2/9 vector in lung. Mol Ther 17:2078-87
Limberis, Maria P; Vandenberghe, Luk H; Zhang, Liqun et al. (2009) Transduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro. Mol Ther 17:294-301
Tertilt, Christine; Joh, Ju; Krause, Anja et al. (2009) Expression of B-cell activating factor enhances protective immunity of a vaccine against Pseudomonas aeruginosa. Infect Immun 77:3044-55
Limberis, M P; Bell, C L; Wilson, J M (2009) Identification of the murine firefly luciferase-specific CD8 T-cell epitopes. Gene Ther 16:441-7

Showing the most recent 10 out of 85 publications